{"id":"NCT02307682","sponsor":"Alcon Research","briefTitle":"Efficacy and Safety of RTH258 Versus Aflibercept - Study 1","officialTitle":"A Two-Year, Randomized, Double-Masked, Multicenter, Three-Arm Study Comparing the Efficacy and Safety of RTH258 Versus Aflibercept in Subjects With Neovascular Age-Related Macular Degeneration","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-12-08","primaryCompletion":"2017-04-22","completion":"2018-03-28","firstPosted":"2014-12-04","resultsPosted":"2019-10-31","lastUpdate":"2025-01-16"},"enrollment":1775,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Neovascular Age-Related Macular Degeneration","Choroidal Neovascularization"],"interventions":[{"type":"DRUG","name":"Brolucizumab ophthalmic solution","otherNames":["RTH258"]},{"type":"DRUG","name":"Aflibercept ophthalmic solution","otherNames":["EYLEAÂ®"]}],"arms":[{"label":"Brolucizumab 3 mg","type":"EXPERIMENTAL"},{"label":"Brolucizumab 6 mg","type":"EXPERIMENTAL"},{"label":"Aflibercept 2 mg","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare brolucizumab (RTH258) ophthalmic solution for intravitreal (IVT) injection at two dosage levels (3 mg and 6 mg) to aflibercept ophthalmic solution for IVT injection (2 mg) in subjects with untreated active choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) in the study eye.","primaryOutcome":{"measure":"Change From Baseline in Best Corrected Visual Acuity (BCVA) (Letters Read) at Week 48 - Study Eye","timeFrame":"Baseline, Week 48","effectByArm":[{"arm":"Brolucizumab 3 mg","deltaMin":5.9,"sd":13.49},{"arm":"Brolucizumab 6 mg","deltaMin":6.4,"sd":14.4},{"arm":"Aflibercept 2 mg","deltaMin":7,"sd":13.16}],"pValues":[{"comp":"OG000 vs OG002","p":"0.0003"},{"comp":"OG001 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":7},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["39033924","38360182","34968756","33207259","30986442"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":94,"n":358},"commonTop":["Nasopharyngitis","Urinary tract infection","Conjunctival haemorrhage - Study eye","Neovascular age-related macular degeneration - Fellow eye","Visual acuity reduced - Study eye"]}}